202) Those in the DOHBIT group, when compared with those in the unsupervised self-treatment group, had significantly lower relative risk (RR) of anemia (16.8% vs 35.3%, RR = 0.47 [95% confidence interval (CI) = 0.33-0.65]; P < .0001), higher hemoglobin (Hb) rise of ≥2 g/dL (70.2% vs 42.2%, RR = 1.56 [95% CI = 1.31-1.87]; P <.0001), and nonsignificant trend for lower side effects (3.5% vs 6.7%, RR = 0.49 [95% CI = 0.22-1.08; P < .08) on intention-to-treat analyses. |
(1)94 of | (11)7 obtained | (21)3 seen | (31)2 on |
(2)60 with | (12)4 aged | (22)3 whose | (32)2 parameters |
(3)46 who | (13)4 at | (23)2 abilities | (33)2 prepared |
(4)40 in | (14)4 individuals | (24)2 between | (34)2 published |
(5)14 without | (15)4 related | (25)2 carrying | (35)2 regions |
(6)12 that | (16)4 reported | (26)2 completing | (36)2 responsible |
(7)9 found | (17)3 born | (27)2 experienced | (37)2 studies |
(8)8 from | (18)3 not | (28)2 fed | |
(9)8 observed | (19)3 older | (29)2 infected | |
(10)7 living | (20)3 receiving | (30)2 involved |
add keyword